HMGB1 and cancer: Thus, it is of extreme importance to further elucidate underlying mechanisms involving HMGB1 signaling in pathology, in order to possibly one day use it as a therapeutic target, prognostic or even diagnostic biomarker in patients suffering from autoimmune disorders and cancer.